Faeth Therapeutics Reports Q3 2026 Financial Results

What Happened
Faeth Therapeutics, Inc. (FTH) filed a Form 8-K on August 4, 2026 (Item 2.02) announcing its financial results for the quarter ended June 30, 2026. The company issued a press release reporting those quarterly results; the press release is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: August 4, 2026 (Form 8-K, Item 2.02).
• Reporting period: Quarter ended June 30, 2026 (Q3 2026).
• Disclosure: Financial results announced via press release included as Exhibit 99.1 to the 8-K.
• Exhibit listed under Item 9.01(d): Exhibit 99.1 (press release).

Why It Matters
Quarterly financial results provide investors with updated information on Faeth’s recent operating and financial performance, which can affect assessments of revenue, cash position, and near-term plans. This 8-K signals that material financial information was released publicly on August 4, 2026; investors should review the attached press release (Exhibit 99.1) for the specific revenue, earnings, and commentary referenced in the filing.